Company Overview of Curidium Medica Limited
Curidium Medica Limited identifies medicines and companion diagnostics for the treatment of central nervous system disorders. It offers PsychINDx, a blood diagnostic test to classify patients with schizophrenia/bipolar disorder in subgroups. The company was founded in 2001 and is based in London, the United Kingdom. Curidium Medica Limited operates as a subsidiary of Avacta Group Plc.
London, WC1H 9BY
Founded in 2001
44 20 7554 5100
44 20 7383 2973
Key Executives for Curidium Medica Limited
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Curidium Medica Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.